Avidity Biosciences, Inc. Profile Avatar - Palmy Investing

Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead produc…

Biotechnology
US, San Diego [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of RNA's Analysis
CIK: 1599901 CUSIP: 05370A108 ISIN: US05370A1088 LEI: - UEI: -
Secondary Listings
RNA has no secondary listings inside our databases.